Amplitude Vascular Systems (AVS) announced results from the first 95 patients treated in the POWER PAD II United States ...

BD announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY investigational device exemption (IDE) ...

Johnson & Johnson MedTech announced 1-year results from the DISRUPT BTK II postmarket study, demonstrating sustained safety ...

Penumbra, Inc. announced that results of the STORM-PE randomized controlled trial (RCT) were presented at VIVA 2025, the Vascul ...

InspireMD, Inc. announced the appointment of Peter A. Soukas, MD, as Chief Medical Officer. InspireMD is the developer of the C ...

Contego Medical announced 30-day outcomes from the PERFORMANCE III study evaluating the Neuroguard IEP system for direct transc ...

Endovascular Engineering, Inc. (E2) announced positive results from the pivotal cohort of the ENGULF investigational device exe ...

The Centers for Medicare & Medicaid Services (CMS) has released the final National Coverage Determination (NCD) on renal de ...

Elucid announced the launch of its PlaqueIQ image analysis software for the quantification and classification of plaque ...

Gore & Associates announced FDA approval of a 6- to 10-mm diameter range for the Viatorr TIPS—transjugular intrahepat ...

HistoSonics, Inc., developer of the Edison histotripsy system and histotripsy therapy platform, announced the closing of $250 m ...

The PERT Consortium announced the launch of The PRISM Program, an initiative to expand access, collaboration, and excellence ...